JENNA FRANZ: Open Payments
NPI 1164066106 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 33 payments from 16 companies in 2025. Trend: 2023 $763 · 2024 $897 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $138 |
| PFIZER INC. | 5 | $88 |
| Amgen Inc. | 4 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| SHIELD THERAPEUTICS INC | 2 | $37 |
| ABBVIE INC. | 2 | $33 |
| Boston Scientific Corporation | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
Products named: Ozempic, Kerendia, NURTEC ODT, Wegovy, ACCRUFER, EVENITY, OTEZLA, UBRELVY.
Industry payments across GA — which companies pay providers there.
